Affinia Therapeutics Receives European Medicines Agency Orphan Drug Designation for AFTX-201 in BAG3-Associated Dilated Cardiomyopathy (DCM)

BAG3 DCM is a devastating genetic heart disease caused by a mutation in the BAG3 gene…

MEFA Announces Transition of U.Plan Prepaid Tuition Program to New Online Platform Powered by Catalis

BOSTON–(BUSINESS WIRE)–#collegesavings–MEFA today announced that its prepaid tuition program, the U.Plan, will transition to a new…

Verastem Oncology to Report Fourth Quarter and Full Year 2025 Financial Results on March 4, 2026

BOSTON–(BUSINESS WIRE)–Verastem Oncology (Nasdaq: VSTM), a biopharmaceutical company committed to advancing new medicines for patients with…

Delta Galil Reports Fourth Quarter and Full Year 2025 Results

Record Fourth Quarter and Full Year Sales Record Fourth Quarter Direct-To-Consumer Sales Record Fourth Quarter Gross…

Zywave Unveils Winter 2026 Release to Help Brokers Win More Deals Faster

Four new AI agents combined with other technology advancements significantly streamline workflows, empowering producers to focus…

BrightView Expands Golf Course Management Partnership with The Villages®

BLUE BELL, Pa.–(BUSINESS WIRE)–BrightView Landscapes, (NYSE: BV), the nation’s leading commercial landscaping services provider and golf…

Jensen Partners Named Recruitment Company of the Year: Investor Relations & Asset Raising at the 2026 Private Equity Wire® European Awards

Recognition highlights the firm’s leadership in capital formation and investor relations recruitment across European private markets…

SolarEdge Announces Fourth Quarter and Full Year 2025 Financial Results

MILPITAS, Calif.–(BUSINESS WIRE)–SolarEdge Technologies, Inc. (Nasdaq: SEDG), a global leader in smart energy technology, today announced…

Starlab Space Announces Partnership with Helogen to Advance Life Sciences Research in Microgravity

The Helogen HEL-IOS™ orbital biomedical operating system will be integrated in the Starlab space station to…

PROG Holdings Reports Fourth Quarter 2025 Results

Consolidated revenues from Continuing Operations of $574.6 million; Net earnings of $40.5 million Adjusted EBITDA from…